Like Ovia Health

closed 8/12/2021 via BusinessWire

LabCorp, acquired Ovia Health

synopsis: Labcorp, a leading global life sciences company, announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.
buyer: LabCorp (LH:$16,388.10)
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. "
target: Ovia Health
Ovia Health is the leading maternity and family benefits solution for employers and health plans. Their consumer apps, Ovia Fertility, Ovia Pregnancy, and Ovia Parenting, help women and families make important life and health decisions on the parenthood journey.
price ($mm)
rev ($mm)
$20
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 1/1/2021 via GlobeNewswire

REGO, acquired Chore Check

synopsis: REGO Payment Architectures, Inc., a digital wallet for the entire family, has acquired Chore Check, LLC, a chore management and allowance app that helps parents to raise self-sufficient kids. Chore Check allows parents to create and schedule chores for each child. The app helps children to track their chores and earn allowance from their parents.
buyer: REGO (OTCPK:RPMT:$0.00)
REGO is a digital wallet for the entire family. REGO enables children to make online purchases that are parent controlled and monitored. The app allows parents to enable online shopping or digital spending at approved retailers, control available funds, and reward children. "
target: Chore Check
Chore Check is a chore management and allowance app that helps parents to raise self-sufficient kids. Chore Check allows parents to create and schedule chores for each child. The app helps children to track their chores and earn allowance from their parents.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2017 via BNC Analysis

Mom2Mom, acquired Bipfun SARL

synopsis: Mom2Mom, the platform that puts mothers in contact to offer care services for their children, has acquired French firm Bipfun. Bipfun is a technology platform established in Marseilles (France) that codes, designs and creates applications for parents.
buyer: Mom2Mom
Mom2Mom is a social network that reinvents the current system of nanny services by connecting mothers interested in caring for children in exchange of time or money. Mom2Mom is a platform that geo-locates mothers who offer or look for babysitting services through a simple, practical and free app. "
target: Bipfun SARL
Bipfun is a technology platform established in Marseilles (France) that codes, designs and creates applications for parents, which currently includes proposals such as Baby Songs, Baby Cloud, Baby Night Light and Baby Monitor.
price ($mm)
$1.34
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2019 via BNC Analysis

Transaction Services Group, will acquire Xplor Australia

synopsis: Transaction Services Group (TSG), a global leader in revenue management solutions, will acquire Xplor, a leading Australian ed-tech company focused on child care services. Xplor's SaaS platform and mobile solutions help child care centres to easily manage and automate all aspects of their operations.
buyer parent: Advent International
buyer: Transaction Services Group
TSG is a global provider of integrated software and payment solutions to the health & wellness and childcare sectors. TSG helps gyms, community clubs, and childcare centres manage their members and customer, driving member retention and revenue performance while reducing costs. "
target: Xplor Australia
Xplor is a leading Australian ed-tech company focused on child care services. Xplor offers a range of products for supporting administrators, educators and parents. Their SaaS platform and mobile solutions help child care centres to easily manage and automate all aspects of their operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2019 via BNC Analysis

Apple, Inc., acquired Tueo Health

synopsis: Apple has acquired Tueo Health, a small start-up that was developing a system to help parents monitor asthma symptoms in sleeping children. Tueo Health was developing a mobile app that worked with commercial breathing sensors to manage asthma symptoms in children. The app would send alerts to parents if their child’s breathing changed at night.
buyer: Apple, Inc. (AAPL:$347,155.00)
Apple revolutionized personal technology with the introduction of the Macintosh in 1984. Today, Apple leads the world in innovation with iPhone, iPad, Mac, Apple Watch and Apple TV. Apple’s four software platforms—iOS, macOS, watchOS and tvOS—provide seamless experiences across all Apple devices. "
target: Tueo Health
Tueo Health is a digital health solution for improved asthma management empowering patients and their families to take control of the disease. The Tueo Health Solution is designed to help parents make informed changes to their child’s environment and treatment through daily symptom assessment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2020 via BNC Analysis

Humanoo, acquired wePulse

synopsis: The Berlin-based digital health platform HUMANOO has taken over the French corporate health platform wePulse. Both companies specialize in corporate health and motivate employees and policyholders across Europe to adopt a healthier lifestyle through digital reward systems and innovative gamification features.
buyer: Humanoo
With more than 300 large corporate customers, Berlin-based HUMANOO is Europe's leading company in the field of digital corporate health and dynamic premium solutions. HUMANOO offers over 1,500 coaching sessions in the areas of exercise, mindfulness and nutrition. "
target: wePulse
wePulse is a French corporate health platform that motivates employees to get moving. wePulse allows employees to digitally track their fitness and health related activity with connected devices such as Garmin, which can be rewarded with value from participating brands and communities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

Nox Medical Global, acquired FusionHealth

synopsis: Nox Medical, the Icelandic maker of sleep monitoring and diagnostics devices, and FusionHealth, have merged to become Nox Health. FusionHealth is a sleep health technology company that provides employers and healthcare systems with population-based, connected care solutions to address the central problem of poor sleep health.
buyer: Nox Medical Global
Nox Medical is the Icelandic maker of sleep monitoring and diagnostics devices. Nox Medical is an Icelandic company founded in 2006 by engineers, investors and medical professionals with extensive experience in providing industry standard solutions for sleep monitoring and diagnostics. "
target: FusionHealth
FusionHealth is a sleep health technology company that provides employers and healthcare systems with population-based, connected care solutions to address the central problem of poor sleep health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/12/2018 via PR Web

StayWell, acquired Provata Health

synopsis: StayWell, a health empowerment company, has acquired Provata Health, a digital health company that delivers scientifically proven population health programs that include native iOS and Android mobile apps to employers, health plans, and hospital systems. Provata Health serves 500,000 members across 1,000 worksites.
buyer parent: Merck & Co., Inc.
buyer: StayWell
StayWell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. For more than 40 years, the company has been a pioneer in employer well-being and patient education solutions that lower risks and reduce costs. "
target: Provata Health
Provata Health is a digital health company that delivers scientifically proven population health programs that include native iOS and Android mobile apps to employers, health plans, and hospital systems. Provata Health serves 500,000 members across 1,000 worksites.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/9/2016 via BNC Analysis

Reward Gateway, acquired Yomp

synopsis: Yomp, an employee health-and-wellness platform designed to increase productivity, improve attendance and boost engagement in the workplace, has been acquired by Great Hill Partners-backed Reward Gateway.
buyer parent: Great Hill Partners LLC
buyer: Reward Gateway
Reward Gateway provides employee engagement technology to the world’s leading companies. Over 1,200 clients including American Express, Groupon, Yahoo!, IBM and McDonald’s use the company’s products to attract, engage and retain the best employees. "
target: Yomp
Yomp provides a Health & Wellbeing platform proven to increase productivity, reduce absenteeism and boost employee engagement.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2020 via PR Newswire

Sprout at Work, acquired Vivametrica

synopsis: Sprout, a leading global enablement solution for workplace wellbeing, has acquired Vivametrica, a Canadian predictive health data analytics company. With the acquisition, Sprout will add further health data analytics and capabilities to its wellness platform, giving Sprout the ability to deliver substantial additional value to its clients.
buyer: Sprout at Work
Toronto-based Sprout is the leading global enablement solution for workplace wellbeing. Its flexible and holistic strategy empowers organizations to embrace wellbeing by identifying and rewarding healthy behaviors. "
target: Vivametrica
Vivametrica is a Canadian health analytics company that measures and predicts health risks, outcomes, and longevity using data from personal sensors and wearables. The company allows businesses to take the insights derived from health data to use for wholistic care management and long term planning.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/28/2021 via Company Press Release

pme Familienservice GmbH, acquired Mindance GmbH

synopsis: The pme Familienservice Group has acquired Mindance GmbH. With the acquisition of the innovative start-up, pme is supplementing its personal coaching and training offers with digital everyday support for mental health. German start-up Mindance offers a tailor-made complete package of digitized training programs and workshops with certified coaches.
buyer: pme Familienservice GmbH
Based in Germany, the pme Familienservice Group assists working people in crises, e.g. conflicts at work, addiction or partnership problems. With a homecare eldercare service, it relieves working people in the organization and financing of care services and offers psychosocial support. "
target: Mindance GmbH
Mindance is a German startup founded in 2017 by Robin Maier, Lukas Stenzel and David Schumann. To promote the mental health of employees, Mindance offers a tailor-made complete package of digitized training programs and workshops with certified coaches.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2016 via PR Newswire

Zipongo, acquired FillMyFork

synopsis: Zipongo announced it has acquired the team and assets of FillMyFork, a provider of healthy cooking recommendations, nutrition rewards, passive tracking of grocery purchases and related analytics. The acquisition aids Zipongo in its expansion of its Food Benefits Management offering to health plans, employers and health systems.
buyer: Zipongo
Zipongo is "Eating Well Made Simple." Zipongo's platform enables digital nutrition coaching for large employers, health plans and health systems, and provides food utility tools to families that make it easier to consistently select and buy healthy food people love. "
target: FillMyFork
FillMyFork produces a phone app that helps companies and individuals track what they eat and give suggestions on how to improve their diet. Arun Nijhawan and Kartik Shastri founded FillMyFork in 2014 with a mission to help people incorporate evidence-based nutrition into their daily lives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2021 via BNC Analysis

Wellness Coaches USA, acquired Benovate

synopsis: Wellness Coaches, a leading provider of workplace wellness, nutrition, and injury prevention coaching, has acquired Benovate, a next generation digital health and wellness platform for the workplace. Benovate provides an interactive wellbeing platform that provides employees with health content and activities that are relevant to them.
buyer: Wellness Coaches USA
Wellness Coaches is a leading provider of workplace wellness, nutrition, and injury prevention coaching. Wellness Coaches provides personalized onsite and virtual coaching to deliver best-in-class engagement rates, risk reduction, and health improvement outcomes. "
target: Benovate
Benovate is a next generation digital health and wellness platform for the workplace. Benovate provides an interactive wellbeing platform that allows businesses to help their employees make healthy choices. The platform provides employees with health content and activities that are relevant to them.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2021 via PR Newswire

Premise Health, acquired Sonic Boom Wellness

synopsis: Premise Health has acquired Sonic Boom Wellness, a leading provider of corporate wellness technology. With the acquisition, Premise can provide employers and their team members with an interactive wellness platform that complements its digital approach, increases engagement, and integrates across Premise digital and physical healthcare solutions.
buyer parent: OMERS Private Equity
buyer: Premise Health
Premise Health is the leading direct health care company. Premise partners with its clients to connect their populations to high-quality, cost-effective health care through physical (onsite and nearsite wellness centers) and digital (local and 24/7 virtual care and connected devices) access models. "
target: Sonic Boom Wellness
Sonic Boom provides a wellness platform that drives long-term behavior improvement while improving company culture and increasing employee retention. Sonic Boom's robust, comprehensive wellbeing program promotes active engagement through social connectivity and personalized programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/29/2020 via BusinessWire

Ontrak, Inc, acquired LifeDojo

synopsis: Ontrak, Inc. has acquired LifeDojo Inc, a comprehensive, science-backed behavior change platform. The acquisition of LifeDojo enhances Ontrak’s market-leading behavioral health engagement capabilities for new and existing customers, with the addition of the LifeDojo digital tools that drive member value and lower cost.
buyer: Ontrak, Inc (OTRK:$50.17)
Ontrak is an AI and telehealth enabled, virtualized healthcare company. Its Predict-Recommend-Engage platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways for people to follow, and engages people who are not getting the care they need. "
target: LifeDojo
LifeDojo is a comprehensive, science-backed behavior change platform. Supported by decades of public health research, the LifeDojo approach to member-centric behavior change delivers lasting health improvement outcomes, high enrollment, and better engagement than traditional programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/1/2020 via BNC Analysis

Wellable, will purchase Daily Challenge Product from MeYou Health

synopsis: Wellable, a wellness technology platform that enables organizations to create programs that help employees thrive, has acquired Daily Challenge from MeYou Health. Daily Challenge is a clinically validated solution that drives engagement and meaningful individual behavior change across multiple well-being activities.
buyer: Wellable
Wellable is a wellness technology platform that enables organizations to create programs that help employees thrive by engaging them in holistic educational modules and activities. Wellable supplements its digital experience with on-site services and rewards administration to maximize engagement. "
seller: MeYou Health
MeYou Health is a social well-being company dedicated to creating engaging products. Daily Challenge is a clinically validated solution that integrates behavior change and social networking science with gaming principles to drive individual behavior change across multiple well-being activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2019 via BNC Analysis

Verita Healthcare Group, acquired CelliHealth

synopsis: Verita Healthcare Group, a technology company that harnesses the power of MedTech, Analytics and AI, has acquired CelliHealth, a health technology company with a leading edge cloud-based digital healthcare services platform.
buyer: Verita Healthcare Group
Based in Singapore, Verita Healthcare Group is a technology company that harnesses the power of MedTech, Analytics and AI, Verita’s diagnostics and digital health management technologies. They create platforms for precision, preventative, patient-centric healthcare. "
target: CelliHealth
Based in Singapore, CelliHealth is a health technology company with a leading edge cloud-based digital healthcare services platform. CelliHealth enables employers to introduce preventive healthcare, foster a health conscious community and empower employees to take responsibility for their health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/21/2018 via GlobeNewswire

RedBrick Health Corporation will be merged with Virgin Pulse,

synopsis: Virgin Pulse, a leading provider of technology solutions that promote employee engagement and wellbeing, will merge with RedBrick Health, a consumer health engagement company that helps organizations create real behavior change.
buyer parent: Virgin Group, Ltd.
buyer: Virgin Pulse
Virgin Pulse, a leading provider of technology solutions that promote employee engagement and wellbeing, and part of Sir Richard Branson’s Virgin Group, helps employers create workforces that are happier, healthier and ultimately more productive. "
target parent: Marlin Equity Partners
target: RedBrick Health Corporation
RedBrick Health is a consumer health engagement company that helps organizations create real behavior change. Their goal is to help people be healthy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2018 via Company Press Release

Dynamic Health Strategies, Inc., acquired Integrated Wellness Solutions, LLC.

synopsis: Dynamic Health Strategies, LLC (DHS Group) is pleased to announce that it has acquired Integrated Wellness Solutions (IWS), a corporate wellness solution company that focuses on the business-to-business market.
buyer: Dynamic Health Strategies, Inc.
Dynamic Health Strategies (DHS) offers specialized healthcare benefit analysis, auditing, cost-management and reporting software and services. DHS Group’s Employer Solution tool, HealthSpective, is a data warehouse and analytics platform that integrates the full spectrum of health benefits data. "
target: Integrated Wellness Solutions, LLC.
Integrated Wellness Solutions (IWS), a corporate wellness solution company that focuses on the business-to-business market. IWS provides wellness software and is a coaching provider.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2018 via Company Press Release

New Directions Behavioral Health, acquired E4 Health, Inc.

synopsis: New Directions Behavioral Health announced the acquisition of E4 Health’s assets, client base and employees. E4 helps organizations reduce their medical costs by offering ways to help individuals make healthier lifestyle choices and manage chronic illnesses.
buyer: New Directions Behavioral Health
New Directions helps provides managed behavioral health care services, an employee assistance program (EAP), student assistance program, organizational consulting, and health coaching to private and public health plans, Fortune 100 companies, large and medium employers, and labor groups. "
target: E4 Health, Inc.
E4 is revolutionizing the field of Integrated Healthcare Management through their integrated, scalable, and cost-effective solution, HealthMap. Based on clinically validated research, it combines the historically disparate products of EAP, Wellness and Care Coordination.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/12/2021 via BusinessWire

LabCorp, acquired Ovia Health

synopsis: Labcorp, a leading global life sciences company, announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.
buyer: LabCorp (LH:$16,388.10)
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. "
target: Ovia Health
Ovia Health is the leading maternity and family benefits solution for employers and health plans. Their consumer apps, Ovia Fertility, Ovia Pregnancy, and Ovia Parenting, help women and families make important life and health decisions on the parenthood journey.
price ($mm)
rev ($mm)
$20
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 8/12/2021 via BusinessWire

LabCorp, acquired Ovia Health

synopsis: Labcorp, a leading global life sciences company, announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.
buyer: LabCorp (LH:$16,388.10)
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. "
target: Ovia Health
Ovia Health is the leading maternity and family benefits solution for employers and health plans. Their consumer apps, Ovia Fertility, Ovia Pregnancy, and Ovia Parenting, help women and families make important life and health decisions on the parenthood journey.
price ($mm)
rev ($mm)
$20
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 11/29/2011 via BNC Analysis

Noridian Mutual Insurance Company, acquired MDdatacor, Inc.

synopsis: Noridian Mutual Insurance Company (NMIC), d.b.a. as Blue Cross Blue Shield of North Dakota (BCBSND), has acquired MDdatacor, Inc., a Georgia-based technology firm that provides insurance companies and health care providers with revolutionary data-driven solutions.
buyer: Noridian Mutual Insurance Company
With more than 60 years of experience in the health insurance industry, Fargo, N.D.-based Noridian Mutual Insurance Company provides quality health care coverage and supplemental products, including medical, life, disability, long-term care and related insurance coverage. "
target parent: LabCorp
target: MDdatacor, Inc.
MDdatacor enhances healthcare quality through the development of innovative technology solutions to support quality improvement, pay-for-performance and patient-centered care initiatives by payors and physicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2011 via PR Newswire

Technest Holdings, Inc., merged with AccelPath, LLC

synopsis: Technest Holdings, Inc. has announced that it has acquired all of the outstanding membership interests of AccelPath, LLC, a provider of digital telepathology and other services to laboratories and hospitals.
buyer: Technest Holdings, Inc.
Technest is in the business of designing, researching, developing, integrating, selling and supporting three-dimensional imaging devices and systems and intelligent surveillance devices and systems, and three-dimensional facial recognition in the healthcare and security industries. "
target: AccelPath, LLC
AccelPath, based in Westwood, Massachusetts, is pursuing opportunities in telemedicine, primarily providing digital telepathology and other services to laboratories and hospitals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2008 via BusinessWire

ICON Plc, acquired Prevalere Life Sciences, Inc.

synopsis: ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that is has acquired Prevalere Life Sciences Inc., a wholly owned subsidiary of ORS Labs Inc.
buyer: ICON Plc (ICLR:$1,541.91)
ICON Clinical Research is a full service clinical research organization providing a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. "
target parent: Oneida Research Services, Inc.
target: Prevalere Life Sciences, Inc.
Prevalere Life Sciences, Inc. is a contract research organization providing consulting and GLP/cGMP compliant analytical testing services to meet the research and development challenges of the pharmaceutical and biotechnology industries.
price ($mm)
$38
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
closed 11/30/2009 via BusinessWire

PPD, Inc., acquired BioDuro, LLC

synopsis: PPD, Inc. announced it has completed its acquisition of BioDuro LLC, a drug discovery outsourcing company focused on integrated drug discovery programs and services. With this acquisition, PPD now employs more than 1,400 in Asia Pacific and nearly 1,000 people in China.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: BioDuro, LLC
BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing, China. Our priority is providing the highest quality, FDA-compliant services at an affordable cost.
price ($mm)
$49
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$4,730.38)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

Chiltern International Inc., acquired Vigiun

synopsis: Chiltern International Limited, a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas and India, announced the acquisition of Vigiun, a full service Clinical Research Organization located in Sao Paulo, Brazil.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Vigiun
Vigiun is a full service clinical research organization located in Sao Paulo, Brazil.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2009 via BNC Analysis

JLL Partners, acquired Patheon, Inc.

synopsis: JLL Partners Inc. has become the majority shareholder of Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: Patheon, Inc.
Patheon Inc. is a leading provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon provides products and services to more than three hundred of the world's leading pharmaceutical and biotechnology companies.
price ($mm)[EV]
$89 [$300]*
rev ($mm)
$628
EBITDA ($mm)
$82
EV / rev
1.0x
EV / EBITDA
7.4x
closed 2/26/2009 via PR Newswire

ChanTest Corporation, acquired Applied Cell Sciences

synopsis: The leading experts in ion channels and G-protein coupled receptors - key to drug discovery, development, and safety - are now united. ChanTest, the leading provider of ion channel testing services and validated cell lines, announced that it has acquired Rockville, Maryland-based Applied Cell Sciences. ACS is a contract research organization.
buyer: ChanTest Corporation
ChanTest has developed the world’s most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. "
target: Applied Cell Sciences
Applied Cell Sciences delivers high throughput screening reagents and reagent-development services for drug discovery research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/6/2009 via BusinessWire

WIL Research Laboratories, LLC, acquired Midwest BioResearch, LLC

synopsis: WIL Research Laboratories, LLC and WIL Research Holding Company, Inc. announce the acquisition of Midwest BioResearch, LLC. Together, Midwest BioResearch and WIL Research shall integrate their service offerings through scientific collaboration, sharing of best practices and marketing.
buyer: WIL Research Laboratories, LLC
WIL Research Laboratories, LLC is a contract research organization that provides an interdisciplinary approach to non-clinical toxicology, pharmacology, metabolism and both clinical and non-clinical bioanalytical services. "
target: Midwest BioResearch, LLC
Midwest BioResearch, LLC was founded in 2003 by scientists, directors and managers from major pharmaceutical companies to provide drug disposition and toxicology services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2009 via BusinessWire

United BioSource Corporation, acquired Healthcare Project Management

synopsis: United BioSource Corporation has announced the acquisition of HPM (Geneva) SA, a Geneva, Switzerland-based provider of drug safety and pharmacovigilance services, further extending UBC’s reach into the European market.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Healthcare Project Management
Healthcare Project Management (HPM) is a contract research organization founded in 1997 to provide clinical research services to industry as well as academia. Our core services are drug safety, medical writing and scientific consultancy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$4,730.38)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Ovia Health


read more

Ovia Health

Chore Check

Bipfun SARL

Xplor Australia

Tueo Health

wePulse

FusionHealth

Provata Health

Yomp

Vivametrica

Mindance GmbH

FillMyFork

Benovate

Sonic Boom Wellness

LifeDojo

MeYou Health

CelliHealth

RedBrick Health Corporation

Integrated Wellness Solutions, LLC.

E4 Health, Inc.

read more

Ovia Health

read more

Ovia Health

MDdatacor, Inc.

read more

AccelPath, LLC

Invicro, LLC

ImageIQ

Prevalere Life Sciences, Inc.

Bio-Quant, Inc.

BioDuro, LLC

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

Vigiun

Patheon, Inc.

Applied Cell Sciences

Midwest BioResearch, LLC

Healthcare Project Management

Aptuit, Inc.

PAREXEL International Corporation

inVentiv Health, Inc.

Quintiles Transnational Corp.

Geography
Matching Companies
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2021
rev ($mm)
$16,388.10
EBITDA ($mm)
$4,886.00
EBIT ($mm)
$4,358.30
Net Income ($mm)
$2,878.70
Employees
68780
  • drill down
  • watch
Ticker: NEO
 
 
 
 
 
 
 
 
NeoGenomics Laboratories
NeoGenomics Laboratories
NeoGenomics is a leading cancer diagnostic reference laboratory. NeoGenomics offers testing services for oncologists, pathologists, and pharmaceutical centers. Their areas of expertise include cancer cytogenetics, hematologic and solid tumor FISH testing, molecular oncology tests, and more.
year
2020
rev ($mm)
$444.45
EBITDA ($mm)
$23.80
EBIT ($mm)
($11.92)
Net Income ($mm)
$4.17
Employees
1700
  • drill down
  • watch
Ticker: BME:ATRY
 
 
 
 
 
 
 
 
Atrys Health, S.A.
Atrys Health, S.A.
Atrys Health is a biomedical company in Spain dedicated to providing diagnostic services and excellent medical treatments. Their aim is to facilitate patients with individualized therapy, as well as to develop new therapeutic modalities and diagnostic tools.
year
2018
rev ($mm)
$10.43
EBITDA ($mm)
$1.46
EBIT ($mm)
$0.94
Net Income ($mm)
$0.01
Employees
99
  • drill down
  • watch
Ticker: KRBP
 
 
 
 
 
 
 
 
Kiromic
Kiromic
Kiromic is an immuno-oncology, target discovery and gene editing company. Kiromic is developing safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. The company is focused on extending the benefits of immunotherapy by leveraging their DIAMOND AI platform.
year
2021
rev ($mm)
EBITDA ($mm)
($21.04)
EBIT ($mm)
($21.30)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: MD
 
 
 
 
 
 
 
 
MEDNAX, Inc.
MEDNAX, Inc.
MEDNAX, Inc. is a national medical group that comprises the nation's leading providers of neonatal, anesthesia, maternal-fetal and pediatric medical and surgical subspecialty services. The company enhances patient outcomes and provide high-quality, cost-effective care.
year
2021
rev ($mm)
$1,796.98
EBITDA ($mm)
$214.68
EBIT ($mm)
$183.66
Net Income ($mm)
Employees
5600
  • drill down
  • watch
Ticker: TSX:NHC
 
 
 
 
 
 
 
 
Northstar Healthcare Inc.
Northstar Healthcare is a full-service healthcare development and management company. With a collective leadership experience that includes developing and managing over 100 surgical centers, Northstar constantly strives to provide superior medical care and increased patient satisfaction.
year
2014
rev ($mm)
$57.93
EBITDA ($mm)
$11.61
EBIT ($mm)
$10.46
Net Income ($mm)
$3.53
Employees
74
  • drill down
  • watch
Ticker: CNSX:SCRN
 
 
 
 
 
 
 
 
ScreenPro
ScreenPro
ScreenPro provides turnkey coronavirus screening solutions to the private sector. ScreenPro has unique access to multiple manufacturers of high quality South Korean test kits and a strategic partnership with Canvas Labs in Vancouver and Integrated Explorations in Ontario.
year
2020
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.04)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: EXAS
 
 
 
 
 
 
 
 
Exact Sciences
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. Exact Sciences develops diagnostic tests for several types of cancer. Its flagship product is Cologuard, a stool-based DNA test for colorectal cancer.
year
2017
rev ($mm)
$213.82
EBITDA ($mm)
($118.76)
EBIT ($mm)
($133.03)
Net Income ($mm)
Employees
736
  • drill down
  • watch